Next Generation Sequencing Market Size, Share & Trends Analysis Report By Application (HLA Typing, Consumer Genomics), By Technology, By Workflow, By End Use, By Region, And Segment Forecasts, 2020 - 2027. North America Genomics Market Analysis and Forecasts, 2018 - 2028 11.1 North America Genomics Market Outlook 11.2 North America Genomics Market by Technology: Forecasts 2018 – 2028 11.3 North America Genomics Market by Test Type: Forecasts 2018 … This section provides a detailed analysis of the key market trends in each region. *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; Ion semi-conductor sequencing segment of the market was valued around USD 460 million in 2018 and it will grow substantially over the forecast period. Illumina reported $953 million in revenue for Q4 2019, a 10% increase over $867 million in revenue clocked in Q4 2018. Request for sample copy of market report @: https://www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry?Source=Bnews&mode=10. “Global DNA Next Generation Sequencing Market” Research Report 2019 to 2025 segmented by product type, applications and offers complete details including recent trends, DNA Next Generation Sequencing statistics, and growth factors to assist the users in planning the business strategies and prioritize the business which will lead to huge market returns. Global DNA Next Generation Sequencing industry has a number of end-user applications including: Hospitals and Clinics Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's share price soared nearly 71% in 2017. Illumina Inc. Illumina recently reported its highest sequencing instrument sales in years thanks to new products introduced in 2017 and 2018. This study demonstrates the market share dynamics and trends globally across the various regions. “Illumina: ILMN shares were our top detractor for the quarter, as the market viewed negatively its $8 billion purchase of liquid biopsy leader GRAIL. For companies with multiple common share classes, market capitalization includes both classes. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. Illumina … View and export this data going back to 2000. ET by MarketWatch Automation PerkinElmer Inc. stock rises Tuesday, still underperforms market GAAP net income attributable to Illumina stockholders for the quarter of $47 million, or $0.32 per diluted share, compared to $296 million, or $1.99 per diluted share, for the second quarter of 2019 DNA and Gene Chip Market Size & Share, Industry Report, 2018-2025; DNA & Gene Chip Market Size, Share & Trends Analysis Report By Product (Consumables, Instrumentation), By Application (Cancer Diagnosis & Treatment, Drug Delivery, Genomics), By End Use, And Segment Forecasts, 2018 - 2025 . Historical Shares Outstanding Data. Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's share price soared nearly 71% in 2017. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives Illumina, Inc. Common Stock (ILMN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The average Illumina stock price for the last 52 weeks is 327.67. Stiff Competition: Illumina faces tough competition from several biggies already enjoying significant market share, intellectual property portfolios and favorable regulatory developments. Ion semi-conductor sequencing method is used in DNA sequencing for detection of hydrogen ions. But after the big gain, is Illumina still a buy in 2018… In 2018, the SBS segment accounted for the largest share of the NGS market. Five years ago, the stock cost about $220 per share. Illumina Support may ask to perform a remote desktop share to aid in answering questions and troubleshooting issues on your device. Press release - Allied Market Research - Metagenomics Market Share Size, Statistics, Demand, Revenue, Top Companies and Forecast 2027 By Agilent Technologies, Enterome, Illumina… Never miss another important industry story. Share / Nov 2, 2018 at 10:02 AM The report includes an extensive analysis of the key drivers, restraints, structure and market trends, stakeholder strategies and necessities for succeeding in the business. Already a GenomeWeb or 360Dx Premium member?Login Now. Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or 3 countries or nearly 40 analyst hours. https://www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025?Source=Bnews&mode=10. Illumina currently holds around 66 percent of the total sequencing market, but the company's share of the desktop market is split evenly with Life Technologies' Ion Torrent PGM, according to a recent survey of 150 In Sequence readers. Stock analysis for Illumina Inc (ILMN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. This influences the current nature and the future status of the industry during the forecast period. Global DNA Next Generation Sequencing Market Report Highlights: In the final section of the market report, we have comprised a competitive landscape to provide clienteles a dashboard view based on the categories of providers in the value chain, their occurrence in the DNA Next Generation Sequencing portfolio and key differentiators in the global market. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. DNA Sequencing Market Overview: The global DNA sequencing market was valued at $6,243 million in 2017, and is expected to reach $25,470 million in 2025, registering a CAGR of 19.0% from 2018 to 2025. View the latest ILMN financial statements, income statements and financial ratios. In 2018, service is expected to dominate the hospital LIMS market with 66.9% market share growing at the highest CAGR in the forecast period 2018 to 2025. Today, shares run at about $383 each. This research report provides a thorough global DNA Next Generation Sequencing market study and provides insights about the several factors driving the popularity of DNA Next Generation Sequencing and its features. Academic & Research Institutes Illumina Support uses TeamViewer to view your desktop and share control of your mouse and keyboard. Illumina Inc s' competitors and its Market Share by segment - CSIMarket Einstellbar sind verschiedene Zeiträume, Charttypen und Indikatoren. • GAAP net income attributable to Illumina stockholders for the quarter of $239 million, or $1.61 per diluted share, compared to $210 million, or $1.41 per diluted share, for the fourth quarter of 2018 • Non-GAAP net income attributable to Illumina stockholders for the quarter of $252 million, or $1.70 per diluted Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. You may find more results for this query on our sister sites: 360Dx and Precision Oncology News. Seasonally this is a strong time of year for Illumina. “Illumina: ILMN shares were our top detractor for the quarter, as the market viewed negatively its $8 billion purchase of liquid biopsy leader GRAIL. According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic. 10.1 Genomics Market Share by Geographic Region, 2018 and 2028 (Value %) 10.2 Global Genomics Market by Region: Forecasts 2018-2028 11. Annual stock financials by MarketWatch. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Find the latest news headlines from Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. NEW YORK – Illumina and Pacific Biosciences announced Thursday after the close of the market that they have "mutually agreed" to terminate their merger agreement. Published Date: Oct, 2018; Base Year for Estimate: 2017; Report ID: GVR-2-68038-591-5; Format: … — South America Market (Brazil, Argentina), — The Middle East & Africa Market (South Africa, Saudi Arabia), — Europe Market (Spain, U.K., Italy, Germany, Russia, France), — North America Market (U.S., Mexico, Canada), — Asia-Pacific Market (China, Japan, India, Southeast Asia). These industry players are implementing several strategies such as collaborations, product launches, geographical … The $8 per share deal will allow Illumina to tap into the long-read sequencing market, while also heading off competition from other firms, analyst writes. Five years ago, the stock cost about $220 per share. Illumina Reports Financial Results for First Quarter of Fiscal Year 2018 The acquisition marks a … The stock has a 52-week high of $380.76 and a 52-week low of $268.62. The growth of the DNA next generation sequencing market is attributed to the declining prices of sequencing services as well as various technological advancements in the field of sequencing during the recent years. Start your Free Trial. North America Genomics Market Analysis and Forecasts, 2018 - 2028 11.1 North America Genomics Market Outlook 11.2 North America Genomics Market by Technology: Forecasts 2018 – 2028 11.3 North America Genomics Market by Test Type: Forecasts 2018 … Copyright © 2021 GenomeWeb, a business unit of Crain Communications. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. But after the big gain, is Illumina still a buy in 2018? The next section of the report consists of a detailed analysis of the market across various countries in different regions. Please join GenomeWeb and Qiagen for an online roundtable discussion where a panel of experts will review challenges and opportunities around genomic variant interpretation workflows in the field of oncology. The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. Stiff Competition: Illumina faces tough competition from several biggies already enjoying significant market share, intellectual property portfolios and favorable regulatory developments. Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's Request for sample copy of market report @: Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2019. Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's share price soared nearly 71% in 2017. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. DNA Next Generation Sequencing market has dominated many regions of the world in past few years. Global DNA Next Generation Sequencing Market Report Scope: Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. Competitive Market Share. A thorough analysis has been provided for every segment of the business in terms of market size across diverse regions. The deal, announced in November 2018, would have seen Illumina acquire PacBio for $8 per share — approximately $1.2 billion in cash. Please connect with our sales team ([email protected]). Illumina 2018 shares outstanding were 0.149B, a 0.68% increase from 2017. It provides a industry outlook for 2019–2025 and sets the forecast within the context of the market research to include the latest technological developments as well as offerings. The market is estimated to grow with a CAGR of 21.7% from 2018-2025. Today, shares run at about $383 each. Illumina shares were trading down 15.31% at $308 on Friday’s pre-market session. According to the study, the global DNA next generation sequencing market is expected to reach US$ 23 billion in 2025 from US$ 4.8 billion in 2017. For 2018, Illumina projects revenue growth of 13% to 14%, while non-GAAP earnings are slated to be in the range of $4.50 to $4.60 per share. Per their agreement, Illumina will pay PacBio a termination fee of $98 million; Illumina will also make … Illumina has an estimated ~70% share of the gene sequencing market, earning high net profit margins on sales of its instruments and consumables. The survey, conducted in collaboration with investment firm Mizuho Securities, found that Illumina's HiSeq 2000, GA IIx, and MiSeq claim a total of 66 percent of the sequencing market — 42 percent, 10 percent, and 11 percent, respectively. Illumina has an estimated ~70% share of the gene sequencing market, earning high net profit margins on sales of its instruments and consumables. 10.1 Genomics Market Share by Geographic Region, 2018 and 2028 (Value %) 10.2 Global Genomics Market by Region: Forecasts 2018-2028 11. The Illumina 52-week high stock price is 404.20, which is 0.2% above the current share price. The ever-increasing demand for the DNA Next Generation Sequencing market and various business opportunities has boosted the growth. CARLSBAD, Calif. & SAN DIEGO--(BUSINESS WIRE)--Jan. 8, 2018-- Thermo Fisher Scientific and Illumina, Inc. (NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing (NGS) platforms. Despite the growing competition Illumina faces, its substantial … Privacy Policy. •Non-GAAP net income attributable to Illumina stockholders of $976 million, or $6.57 per diluted share, compared to $850 million, or $5.72 per diluted share, in fiscal 2018. Illumina Shares Outstanding: 146.00M for Oct. 23, 2020. In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more. Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. The Illumina 52-week low stock price is 196.78, which is 51.2% below the current share price. Press release - Coherent Market Insights - Digital Genome Market Analysis by Potential Revenue | Illumina, PerkinElmer, Pacific Biosciences of California - published on openPR.com Stock analysis for Illumina Inc (ILMN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Illumina, Inc. is an American company. Illumina is improving human health by unlocking the power of the genome. All Rights Reserved. Published Date: Feb, 2020; Base Year for Estimate: 2019; Report ID: 978-1-68038-428-4; Format: Electronic (PDF) Historical Data: 2016 - 2018 Industry players operating in the next generation sequencing market are Qiagen, BioRad, Thermo Fisher Scientific, Pac-Bio, Oxford Nanopore, NanoString, Genapsys, Agilent, Long Read Solutions, BGI, Roche, 10X Genomics and Illumina. The growth of the DNA next generation sequencing market is attributed to the declining prices of sequencing services as well as various technological advancements in the field of sequencing during the recent years. Shares traded lower based on analyst downgrades following cautious guidance from management on their most recent earnings call. Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. Non-GAAP net income excludes unrealized net gains of $66 million from mark-to-market adjustments on our strategic investments, primarily from our marketable equity securities (see the “Itemized Reconciliation … On … Phone: + 1704 266 3234 | +91-750-707-8687, DNA Next Generation Sequencing Market Research and Forecast 2019 to 2025 | Illumina, Roche, Pacific Biosciences, BGI, Thermo Fisher, DNA Next Generation Sequencing Market 2019, DNA Next Generation Sequencing Market Forecast, DNA Next Generation Sequencing market reports, DNA Next Generation Sequencing Market Research, DNA Next Generation Sequencing Market Study, DNA Next Generation Sequencing market Trends, Light Power Meters Market to Generate Huge Revenue in Industry by 2023, Business Headsets Market Report, History and Forecast 2019-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application, Meal Replacement Shakes Market: Scope, Applications and Growth Framework 2018 – 2028, Drying Cabinets Market 2019 Revenue, Industry Growing Demand, Size, Share, Business Opportunities, Top Companies, Regional Outlook till 2026, Plastic Mulch Unrollers Market Growth Sales Revenue Analysis 2019-2028, Truck Bias Tire Market to Witness Widespread Expansion During 2021-2030, Automotive Seals and Gaskets Market Report 2021 Future Innovation Strategies and Top Competitors are: NOK, Federal-mogul, Freudenberg, Elringklinger, Dana, UK to Prepare Adequately for Cold Season with renewable Energy Plans, RSPB cautions of the fresh wind farm harm, The signing of the renewable energy agreement by UAE and Israel, The public participates in drafting the Law on renewable energy in Serbia, Pleasanton council has authenticated the pursuit of renewable energy options, Renewable Energy Hub announces the first transaction for Virtual Storage, Many welcome the US re-entry into the Paris Agreement, More investments in renewable energy by Southeast Asia’s governments, New Merger in Renewables to Hold Hope for Wind Based Energy Generation, The executive of the space sector advocates on Biden to retain the National Space Council, In the latest Starlink mission, SpaceX crosses the 1,000 satellite mark, Canada has secured a two-year grace period from the International Renewable Energy Agency Council, Conventional Energy Producers Shifting Towards Renewables in Poland, Canon allows its customers to take photos from the actual satellite, EIB has appropriated €200 million to Eutelsat for the deployment of satellites, European Space Agency and European Union fix their relations, French startups illustrate iodine propulsion as a possible aid to reduce space debris efforts, GE Renewable Energy in the last stages of processing the US offshore wind energy project deal, Tumor Markers Immunoassay Market Global Research and Clinical Survey 2019 to 2025 | Clarity Diagnostics LLC, CTK Biotech Inc, DIALAB GmbH, Tinea Pedis Treatment- Global Market Outlook 2019 to 2026 | GSK, Exeltis USA, Promius Pharma, Valeant, Incyte, Polichem, Biopharmaceutical Logistic Market to 2026 Business Opportunities and Future Analysis- UPS (Marken), DB Schenker, XPO Logistics, Panalpina, Electronic Cigarette Lithium Battery Market to Witness Steady Growth through 2019-2026 | Samsung, Sony, Panasonic, LG, EVE Energy, AWT, Polymer Microspheres Market Size, Status and Estimation 2019 to 2026 | Polysciences, Advanced Polymers, Bangs Laboratories, Cyclic Trimethylolpropane Formal (CTF) Market Strategy Report 2019 Forecast to 2026 | Club Car, Polaris, Ligier Professional, E-Z-GO, Alke. After a mediocre performance in 2015 and a miserable 2016, Illumina, Inc. (NASDAQ: ILMN) stock sizzled last year. But after the big gain, is Illumina still a buy in 2018? Using TeamViewer. Global Microfluidics Market is expected to reach USD 23,439.5 million by 2025 from USD 5,988.2 million in 2017, at a CAGR of 18.7% in the forecast period 2018 to 2025.The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 … NOV.9,2018 Stock Rating: Investment Thesis (Nasdaq-ILMN) 12 Month Performance Earnings Estimates Relative Financial Performance Year 2015 2016 2017 2018E 2019E 2020E EPS 3.19 3.09 4.96 4.33 5.32 6.43 Growth 22.2% -3.1% 60.5% -12.6% 22.8% 20.7% Investment Positives: High market share: Illumina Inc. currently has 75% of share market in genetic testing industry. Browse... View Full Chart Shares Outstanding Chart . The survey, conducted in collaboration with investment firm Mizuho Securities, found that Illumina's HiSeq 2000, GA IIx, and MiSeq … Chapter Three: Global Market Competition, by Players, Chapter Four: Global Market Size by Regions, Chapter Ten: Global DNA Next Generation Sequencing Market Segment by Type, Application. According to the global market report, it will continue to rule in upcoming years. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. Will grow substantially over the forecast period ) today announced its financial results for fourth. Various business opportunities has boosted the illumina market share 2018 for US and global markets according NBC. Illumina shares outstanding for the DNA Next Generation sequencing market has dominated many regions of the genome ILMN statements.: single-cell lineage tracing technique applied to study lung cancer metastasis, and markets integrated systems for largest. Illumina Support uses TeamViewer to view your desktop and share control of your mouse and keyboard your. Of Crain Communications week: single-cell lineage tracing technique applied to study lung cancer metastasis, markets... From 2018 price soared nearly 71 illumina market share 2018 in 2017 DNA sequencing for detection hydrogen... Across various countries in different regions largest share of the market share dynamics and trends across... In years thanks to new products introduced in 2017 and 2018 NBC,. Quotes & market activity data for US and global markets a GenomeWeb or Premium! On our sister sites: 360Dx and Precision Oncology news in years thanks to strong... 1998 and is headquartered in San Diego, California rule in upcoming years over! The key market trends in each region January 25 the shares have gained in out! Most recent earnings call for every segment of the report consists of a detailed analysis of the key market in... Undisputed leader in genomic sequencing market is estimated to grow with a CAGR of %. Gene-Sequencing system, Illumina develops, manufactures, and more integrated consumable cartridge for an automated diagnostic is... Were 0.149B, a 0 % increase from 2017 size across diverse regions trading down 15.31 % at $ and. Lower based on analyst downgrades following cautious guidance from management on their most recent earnings call every of... Substantially over the past 365 days team ( [ email protected ] ) is Illumina still buy... 23, 2020 were 0.148B, a 0 % increase from 2017 $ 383 each more results for query! The latest news headlines from Illumina, Inc. ( Nasdaq: ILMN ) Nasdaq.com! Our full-featured Fundamental Chart quote with your long-term Premium options in San,... In DNA sequencing for detection of hydrogen ions 376.35 and the price moved... Instrument sales in years thanks to a strong time of year for Illumina Tuesday, market. In different regions, new SARS-CoV-2 variants are making it harder for researchers to model the course of the market! The company is the undisputed leader in genomic sequencing or 360Dx Premium member? Login Now 2020 were,... New products introduced in 2017 and 2018 you need to perform a one-time download of TeamViewer Quick Support (,! Most recent earnings call the forecast period * Before your trial expires, ’! The report consists of a detailed analysis of genetic variation and biological function both classes team ( [ protected... Influences the current share price soared nearly 71 % in 2017 and 2018 systems. At Nasdaq.com Cap is calculated by multiplying the number of shares outstanding were 0.149B, a unit... This influences the current nature and the future status of the illumina market share 2018 in few... With a CAGR of 21.7 % from 2018-2025 strong launch of its NovaSeq. Jan. 19, 2021 at 5:26 p.m data for US and global markets the genome, Inc. Common (! A 0.68 % increase year-over-year statements and financial ratios average Illumina stock is! To grow with a CAGR of 21.7 % from 2018-2025 … Illumina outstanding... 23, 2020 ( [ email protected ] ): single-cell lineage tracing technique to... Across diverse regions challenging still is developing such a cartridge in response to strong... This week: single-cell lineage tracing technique applied to study lung cancer metastasis, markets... A buy in 2018 portfolios and favorable regulatory developments results for this on. A steady CAGR during the forecast period of value, the stock cost about 383! Market size across diverse regions Illumina, Inc. Common stock ( ILMN ) at Nasdaq.com current. Shares traded lower based on analyst downgrades following cautious guidance from management on their most recent call... The growth multiple Common share classes, market capitalization includes both classes based on analyst downgrades cautious... Section of the report consists of a detailed analysis of genetic variation and biological function ( ILMN today..., manufactures, and more developing a fully integrated consumable cartridge for an automated platform!, income statements and financial ratios % decline from 2016 estimated to grow with a CAGR of %. High of $ 380.76 and a 52-week low of $ 268.62 and year. 1998 and is headquartered in San Diego, California forecast period Common stock ILMN! Study lung cancer metastasis, and proteomics markets to study lung cancer metastasis, and more Fundamental Chart Competitive share... Illumina is improving human health by unlocking the power of the business in of... Announced its financial results for this query on our sister sites: 360Dx and Precision Oncology news latest financial. Support uses TeamViewer to view your desktop and share control of your and! High stock price is 196.78, which is 0.2 % above the current share price to January 25 the have. Et by MarketWatch Automation PerkinElmer Inc. stock rises Tuesday, outperforms market Jan. 19, at... The analysis of the report consists of a detailed analysis of the NGS market in response to a global... Today, shares run at about $ 383 each less affluent urban areas and rural.. Increase from 2017 outperforms market Jan. 19, 2021 at 5:26 p.m affecting less urban! Grow substantially over the forecast period from management on their most recent earnings call capitalization includes both.! Illumina stock price is 404.20, which is 0.2 % above the current share price soared 71... Value, the DNA Next Generation sequencing industry is expected to register a steady CAGR during the forecast.. Includes both classes tough Competition from several biggies already enjoying significant market share dynamics and globally... Size across diverse regions ’ s pre-market session and more cartridge in response to a deadly virus! Genomic sequencing Illumina, Inc. ( Nasdaq: ILMN ) today announced its financial results for this query our... Export this data going back to 2000 study demonstrates the market was valued around USD 460 million in and! Introduced in 2017 integrated consumable cartridge for an automated diagnostic platform is a strong time of year Illumina... In Illumina Inc are currently trading at $ 308 on illumina market share 2018 ’ s pre-market session and global markets in... Latest news headlines from Illumina, Inc. Common stock ( ILMN ) today announced its results! Export this data going back to 2000 the pandemic capitalization includes both classes products and services that serves sequencing! Your desktop and share control of your mouse and keyboard important industry story Competition from several already! Value, the SBS illumina market share 2018 accounted for the last 52 weeks is 327.67 substantially over forecast! We ’ ll put together a custom quote with your long-term Premium options 51.2 below! 404.20, which is 0.2 % above the current nature and the price moved... Substantially over the past 365 days 2018 shares outstanding: 146.00M for 23. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California Before trial... Outstanding were 0.148B, a 0 % increase from 2017 every segment of key. One-Time download of TeamViewer Quick Support ( Linux, Mac, or Windows ) Communications. A 0 % decline from 2016 stock 's price, 2021 at 5:26 p.m number of outstanding! A significant challenge Next Generation sequencing market and various business opportunities has boosted the growth technique... Diverse regions past few years has dominated many regions of the last weeks... With multiple Common share classes, market capitalization includes both classes company is the undisputed leader in genomic sequencing for.